27 related articles for article (PubMed ID: 25386826)
1. Inhibitory neurosteroids and the GABAA receptor.
Seljeset S; Laverty D; Smart TG
Adv Pharmacol; 2015; 72():165-87. PubMed ID: 25600370
[TBL] [Abstract][Full Text] [Related]
2. Dopamine directly modulates GABAA receptors.
Hoerbelt P; Lindsley TA; Fleck MW
J Neurosci; 2015 Feb; 35(8):3525-36. PubMed ID: 25716851
[TBL] [Abstract][Full Text] [Related]
3. Oxytocin prevents ethanol actions at δ subunit-containing GABAA receptors and attenuates ethanol-induced motor impairment in rats.
Bowen MT; Peters ST; Absalom N; Chebib M; Neumann ID; McGregor IS
Proc Natl Acad Sci U S A; 2015 Mar; 112(10):3104-9. PubMed ID: 25713389
[TBL] [Abstract][Full Text] [Related]
4. The diversity of GABA(A) receptor subunit distribution in the normal and Huntington's disease human brain.
Waldvogel HJ; Faull RL
Adv Pharmacol; 2015; 73():223-64. PubMed ID: 25637443
[TBL] [Abstract][Full Text] [Related]
5. Allosteric ligands and their binding sites define γ-aminobutyric acid (GABA) type A receptor subtypes.
Olsen RW
Adv Pharmacol; 2015; 73():167-202. PubMed ID: 25637441
[TBL] [Abstract][Full Text] [Related]
6. New Developments of the Principle of Vinylogy as Applied to π-Extended Enolate-Type Donor Systems.
Curti C; Battistini L; Sartori A; Zanardi F
Chem Rev; 2020 Mar; 120(5):2448-2612. PubMed ID: 32040305
[TBL] [Abstract][Full Text] [Related]
7. Ligands for the benzodiazepine binding site--a survey.
Teuber L; Wätjens F; Jensen LH
Curr Pharm Des; 1999 May; 5(5):317-43. PubMed ID: 10213798
[TBL] [Abstract][Full Text] [Related]
8. Allosteric modulation of GABAA receptors via multiple drug-binding sites.
Sieghart W
Adv Pharmacol; 2015; 72():53-96. PubMed ID: 25600367
[TBL] [Abstract][Full Text] [Related]
9. GABA(A) receptor subtype-selectivity of novel bicuculline derivatives.
Ramerstorfer J; Foppa V; Thiery H; Hermange P; Janody S; Berger ML; Dodd RH; Sieghart W
Curr Med Chem; 2015; 22(6):771-80. PubMed ID: 25386826
[TBL] [Abstract][Full Text] [Related]
10. Subtype selectivity of α+β- site ligands of GABAA receptors: identification of the first highly specific positive modulators at α6β2/3γ2 receptors.
Varagic Z; Ramerstorfer J; Huang S; Rallapalli S; Sarto-Jackson I; Cook J; Sieghart W; Ernst M
Br J Pharmacol; 2013 May; 169(2):384-99. PubMed ID: 23472935
[TBL] [Abstract][Full Text] [Related]
11. GABAA receptor subtypes: autoradiographic comparison of GABA, benzodiazepine, and convulsant binding sites in the rat central nervous system.
Olsen RW; McCabe RT; Wamsley JK
J Chem Neuroanat; 1990; 3(1):59-76. PubMed ID: 2156526
[TBL] [Abstract][Full Text] [Related]
12. Differential cross talk of ROD compounds with the benzodiazepine binding site.
Sigel E; Baur R; Furtmueller R; Razet R; Dodd RH; Sieghart W
Mol Pharmacol; 2001 Jun; 59(6):1470-7. PubMed ID: 11353808
[TBL] [Abstract][Full Text] [Related]
13. Positive modulation of synaptic and extrasynaptic GABAA receptors by an antagonist of the high affinity benzodiazepine binding site.
Middendorp SJ; Maldifassi MC; Baur R; Sigel E
Neuropharmacology; 2015 Aug; 95():459-67. PubMed ID: 25963418
[TBL] [Abstract][Full Text] [Related]
14. Unexpected Properties of δ-Containing GABAA Receptors in Response to Ligands Interacting with the α+ β- Site.
Mirheydari P; Ramerstorfer J; Varagic Z; Scholze P; Wimmer L; Mihovilovic MM; Sieghart W; Ernst M
Neurochem Res; 2014 Jun; 39(6):1057-1067. PubMed ID: 24072672
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
